BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Down 67.1% in November

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 7,300 shares, a decrease of 67.1% from the October 31st total of 22,200 shares. Based on an average trading volume of 23,900 shares, the days-to-cover ratio is presently 0.3 days.

BetterLife Pharma Stock Up 10.1 %

Shares of OTCMKTS BETRF traded up $0.01 during midday trading on Friday, hitting $0.09. The company had a trading volume of 25,900 shares, compared to its average volume of 12,844. The firm has a market capitalization of $11.75 million, a price-to-earnings ratio of -3.03 and a beta of 1.27. BetterLife Pharma has a twelve month low of $0.03 and a twelve month high of $0.15. The business has a 50-day simple moving average of $0.09 and a two-hundred day simple moving average of $0.09.

BetterLife Pharma (OTCMKTS:BETRF) last posted its quarterly earnings data on Wednesday, September 25th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.